Her oncologist, Dr. Luis Raez, recommended Lynn undergo a Guardant360 liquid biopsy test, and the results confirmed an EGFR mutation that about 15% of lung cancer patients have. Dr. Raez discussed the results with Lynn and suggested a targeted therapy specific to her cancer type that would allow her to continue living a normal, active life..